Previous Article | Next Article 
Journal of Virology, August 2001, p. 7230-7243, Vol. 75, No. 16
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7230-7243.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Hydrophobic Amino Acids in the Human Immunodeficiency Virus
Type 1 p2 and Nucleocapsid Proteins Can Contribute to the Rescue of
Deleted Viral RNA Packaging Signals
Liwei
Rong,1,2
Rodney S.
Russell,1,3
Jing
Hu,1
Yongjun
Guan,1
Lawrence
Kleiman,1,3
Chen
Liang,1,2,* and
Mark A.
Wainberg1,2,3,*
McGill AIDS Centre, Lady Davis
Institute-Jewish General Hospital, Montreal, Quebec, Canada H3T
1E2,1 and Departments of
Medicine2 and Microbiology and
Immunology,3 McGill University, Montreal,
Quebec, Canada H3A 2B4
Received 28 February 2001/Accepted 27 April 2001
 |
ABSTRACT |
An RNA fragment of 75 nucleotides, which is located between the
primer binding site and the 5' major splice donor site in human
immunodeficiency virus type 1, has been shown to participate in
specific encapsidation of viral RNA. Compensation studies have identified two second-site mutations, namely, MP2 (a T12I substitution in p2) and MNC (a T24I substitution in the nucleocapsid [NC] protein) that were involved in the rescue of various deletions in the
aforementioned RNA region (i.e., BH-D1, BH-D2, and BH-LD3). To study
whether the MP2 and MNC point mutations exert their compensatory
effects in a cis manner, production of Gag proteins was
blocked by insertion of stop codons into LD3, LD3-MP2-MNC, and
wild-type BH10 such that the constructs generated, i.e., LD3-DG,
LD3-MP2-MNC-DG, and BH-DG, only provided RNA transcripts for packaging.
The results of cotransfection experiments showed that the
LD3-MP2-MNC-DG viral RNA was packaged as inefficiently as LD3-DG; in
contrast, BH-DG was efficiently packaged. Therefore, nucleotide
substitutions in MP2 and MNC did not act in a cis manner to
correct the packaging deficits in LD3. Next, we deliberately changed
the T12 in p2 or the T24 in the NC to each of 19 other amino acids. We
found that amino acids with long hydrophobic side chains, i.e., V, L,
I, and M, were favored at either position 12 in p2 or at position 24 in
NC to compensate for the above-mentioned deletions. Further studies
showed that only a few amino acids could not be used at these two sites
by the wild-type virus due to decreased RNA levels in the virion or
abnormal Gag protein processing. In this case, W, D, and E could not
substitute for T12 in p2, and S, D, and N could not substitute for T24
in NC, without affecting viral infectivity. Therefore, the long
hydrophobic side chains of V, L, I, and M are necessary for these amino
acids to rescue the BH-D1, BH-D2, and BH-LD3 mutated viruses.
 |
INTRODUCTION |
Human immunodeficiency virus type 1 (HIV-1) encapsidates two copies of full-length viral RNA that form a
dimer through noncovalent linkage at the 5' end (5). The
cis-acting elements that are involved in the specific
packaging and dimerization of viral RNA are located in the 5' viral RNA
leader sequence. Complex secondary structures have been proposed to
exist in the leader region, among which SL1 and SL3 can bind to
nucleocapsid (NC) protein with high affinity and are thought to be the
major RNA elements responsible for viral RNA encapsidation (2, 7,
17, 19, 23, 27, 28). SL1 has also been shown to function as the
dimerization initiation site (DIS) for viral RNA (1, 3, 9, 13,
19-22, 26, 30-34, 37). In addition, although the TAR and
poly(A) hairpins, which are located at the 5' end of the leader
sequence, bind to NC protein with low affinity, they have also been
shown to contribute to the packaging process (10, 11, 16, 17,
29).
We have been particularly interested in the roles of RNA sequences,
located upstream of the 5' major splice donor (SD) site, in
encapsidation of viral RNA, since these RNA sequences are contained in
both spliced and unspliced viral RNA, yet help the virus to selectively
recruit unspliced RNA while excluding spliced RNA. To shed light on
this issue, a number of deletion mutations, termed BH-D1, BH-D2, and
BH-LD3, have been constructed to selectively remove RNA sequences in
this region (23-25). These deletions had adverse impacts
on both viral RNA encapsidation and viral replication. Interestingly,
when the mutated viruses were cultured for a prolonged period,
revertants with wild-type replication kinetics arose, and the results
of sequencing analysis revealed two substitutional mutations, i.e., MP2
(T12I in p2) and MNC (T24I in NC), that can rescue such mutated
viruses. We believe that exploration of the mechanism by which the MP2
and MNC mutations are able to compensate for the functions of the
deleted RNA sequences will add new insights into the roles of RNA
sequences upstream of the 5' SD site in viral RNA encapsidation and
viral replication.
The first question we sought to answer was whether changes of
nucleotides by the MP2 and MNC point mutations had altered
cis-acting RNA signals in the gag coding region
and whether the compensatory effects obtained were controlled in a
cis-acting manner. This subject was pursued by insertion of
stop codons into the gag gene in LD3, LD3-MP2-MNC, and BH10
to block Gag production, in order to enable a comparison of packaging
efficiency among these three viral RNA transcripts. The second issue
was whether the I residue is the only amino acid at either position 12 in p2 or at position 24 in NC that can rescue the above deletions.
Answers to this question will shed light on the strictness of the
steric interactions at these two sites for the rescue process. This
subject was approached by substituting either the T12 in p2 or the T24
in NC by each of 19 other amino acids and screening for those residues
that are able to rescue the deletions described above.
 |
MATERIALS AND METHODS |
HIV-1 DNA mutagenesis.
The BH10 clone of infectious HIV-1
cDNA was employed as starting material to generate the following mutant
constructs. The BH-D1, BH-D2, and BH-LD3 deletions eliminated sequences
at nucleotides (nt) +200 to +226, +200 to +233, and +238 to +253,
respectively, and were constructed as previously described (23,
25). To prevent translation of Gag proteins, stop codons were
inserted at both the 6th and 8th amino acid positions in matrix (MA)
protein and the 82nd and 85th amino acid positions in capsid (CA)
protein (Fig. 1A). The former two stop
codons in MA were engineered by PCR through use of primer pair pBssH-S
(5'-CTGAAGCGCGCACGGCAAGAGG-3' [positions 706 to
727])-p800 (5'-CTAATTCTCCCCCGCTTCATACTCACGCTCTCGCACCC-3' [positions 829 to 792]); the latter two stop codons in CA were inserted by PCR through use of primer pair pBssH-S-p1430
(5'-GCCCTGCATGCACTTAATGCACTCAATCCCATTCTGC-3' [positions
1453 to 1417]). The entire DIS sequences at nt +243 to +277 were
deleted in construct
DIS that was generated by PCR using the primer
pair pHpa-S (5'-CTGCAGTTAACTGGAAGGGCTAATTCACTCCC-3' [positions 1 to 21])-pDIS
(5'-TACTCACCAGTCGCCGCCCTCCTGCGTCGAGAGAGC-3' [positions 750 to 680]).

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Schematic illustration of the inserted stop codons
in the gag gene. The mutated nucleotides are underlined. (B)
Analysis of viral protein expression from various constructs in
transfected COS-7 cells. The top, middle, and bottom panels represent
Western blots performed with MAbs against HIV-1 CA (p24), MA (p17), and
Env proteins, respectively. A fusion protein of ~25 kDa that contains
MA and truncated CA sequences is indicated by a star in the middle
panel. Protein markers are shown on the right of the gels. BH- MA
contains stop codons in MA. BH- CA contains stop codons in CA. BH-DG
contains stop codons in both MA and CA. LD3-DG contains the LD3
deletion, as well as stop codons in MA and CA. LD3-MP2-MNC-DG contains
the LD3 deletion and the MP2 and MNC point mutations, as well as stop
codons in MA and CA.
|
|
An amino acid T at position 12 in the p2 protein was substituted by
each of 19 other amino acids through use of primer p2-12X
(5'-CCAAGTAACAAATTCAGCT
NNNATAATGATGCAGAGAGGC-3'
[positions 1893
to 1932]), in which N represents A, C, G, or T;
this permits each
of the 20 amino acids to appear at this site (see
Fig.
3). PCR
was performed with the primer pair p2-12X-pNC-A
(5'-TTAGCCTGTCTCTCAGTACAATC-3'
[positions 2084 to 2062]),
and the initial PCR product was used
as a primer in a second round of
PCR along with primer pSph-S
(5'-AGTGCATCCAGTGCATGCAGGGCC-3'
[positions 1431 to 1454]). The
final PCR product was digested
with restriction enzymes
SphI and
ApaI and
inserted into BH-D1 or BH10 to generate clones D1-p2-12X
or BH-p2-12X
(X represents any of the 20 amino acids). A large
number of bacterial
colonies were screened to ensure representation
of substitutions of all
20 amino acids at position 12 in
p2.
The amino acid T residue at position 24 in NC was substituted by each
of 19 other amino acids with the same cloning strategy
using primer
pair pNC-24X
(5'-CCTAGGGGCCCTGCAATTTCTGGC
NNNGTGCCCTTCTTTGC-3'
[positions 2007 to 1966])-pSph-S to generate clones
D2-MP2-NC24X
(containing the D2 deletion and MP2 substitution) or
BH-NC24X.
Primer positions refer to the beginning of the 5' U3 region.
All
primers were synthesized by Gibco-BRL.
Cell culture, transfection, and infection.
COS-7 and MT-2
cells were grown in Dulbecco modified Eagle medium (DMEM) and RPMI 1640 medium, respectively, each supplemented with 10% fetal calf serum.
COS-7 cells were transfected with HIV-1 DNA constructs in the presence
of Lipofectamine (Gibco-BRL, Montreal, Quebec, Canada). Progeny virus
was harvested 48 h after transfection and quantified by measuring
levels of viral CA antigen (Ag) by enzyme-linked immunosorbent assay
(Abbott Laboratories, Abbott Park, Ill.).
For infectivity assays, similar amounts of virus (i.e., 3 ng of CA Ag)
were used to infect 5 × 10
5 MT-2 cells. After 2 h, cells were washed twice to remove unbound
virus and grown in
complete RPMI 1640 medium. Culture fluids were
collected at various
times, and reverse transcriptase (RT) activity
was measured
(
23).
For mutated viruses with diminished infectiousness, the infected cells
were split upon confluence and kept in culture until
extensive
formation of syncytia and high levels of RT activity
were observed. At
this stage, culture fluids were used to infect
fresh MT-2 cells.
Viruses were passaged until the infections observed
were as virulent as
those caused by wild-type virus. Cellular
DNA was purified and
amplified by PCR through the use of primer
pair pHpa-S-pBcl-A
(5'-CTATGAGTATCTGATCATACTG-3' [positions 2445
to 2424]).
The PCR product was cloned and sequenced to confirm
the presence of the
original mutations and to identify novel mutations
that might have been
present in noncoding leader RNA sequences
and in the
gag gene.
Radiolabeling and immunoprecipitation assays.
COS-7 cells
that had been transfected with HIV-1 recombinant DNA constructs were
starved in DMEM without L-Met and L-Cys at 37°C for 1 h, after which the cells were metabolically
radiolabeled with [35S]-L-Met and
[35S]-L-Cys (ICN) at a concentration of 100 µCi/ml for 30 min at 37°C. After an extensive washing with complete
DMEM, supplemented with 30 µg of L-Met and 60 µg of
L-Cys per ml, the cells were cultured for 1 h. Virus
particles from culture fluids were pelleted by ultracentrifugation and
analyzed on sodium dodecyl sulfate (SDS)-12% polyacrylamide gels. The
cells were washed twice with cold phosphate-buffered saline and lysed
with 1 ml of NP-40 lysis buffer (50 mM Tris-Cl [pH 8.0], 150 mM NaCl,
0.02% sodium azide, 100 µg of phenylmethysulfonyl fluoride per ml, 1 µg of aprotinin per ml, and 1% NP-40). The cell lysates were
clarified in a bench-top Eppendorf centrifuge at 13,000 rpm for 10 min
at 4°C and then incubated with anti-HIV-1 CA monoclonal antibody
(MAb) for 1 h at 4°C, after which 5 µl of protein-A linked
Sepharose 4B (Pharmacia, Montreal, Quebec, Canada) was added for a
further 30 min of incubation. The Sepharose 4B was then centrifuged and
washed in turn with NET-gel buffer and Tris-NP-40 buffer
(35). Pellets were suspended in 20 µl of 1×
SDS-containing gel-loading buffer, boiled, and analyzed by SDS-12%
polyacrylamide gels. Viral proteins were visualized by exposure to
X-ray films.
Encapsidation of viral RNA by RT-PCR.
Supernatants from
COS-7 cells that had been transfected with various HIV-1 recombinant
DNA constructs were clarified in a Beckman GS-6R centrifuge at 3,000 rpm for 30 min at 4°C and quantified on the basis of CA Ag levels.
Viral RNA was purified from an amount of virus containing 2 ng of CA Ag
using an RNA extraction kit (Qiagen). Viral RNA was dissolved in 50 µl of diethyl pyrocarbonate-treated water and treated with 20 U of
RNase-free DNase (Gibco-BRL, Montreal, Quebec, Canada) at 37°C for 30 min to remove any DNA contamination. Five-microliter volumes of viral
RNA were amplified for 20 cycles with a Titan One-Tube RT-PCR system
(Boehringer Mannheim, Mannheim, Germany) using primer pair pGAG1-pST to
analyze full-length viral RNA (23). DNA products were
analyzed on 5% native polyacrylamide gels and visualized following
exposure to X-ray films.
Transfected COS-7 cells were washed twice with cold phosphate-buffered
saline and were lysed with NP-40 lysis buffer. A portion
of the lysates
was removed for p24 determination, and the rest
were subjected to RNA
extraction with Trizol Reagent (Gibco-BRL).
RNA from 200 pg of cell
lysates was analyzed by RT-PCR as described
above.
 |
RESULTS |
The MP2 and MNC point mutations do not exert their compensatory
effects via a cis-acting mechanism.
Since MP2 and MNC
compensate for cis-acting viral RNA packaging signals, it
may be speculated that these two mutations act by changing
cis-acting RNA signals in the gag-coding region.
It was shown that MP2 and MNC restored the diminished content of viral
RNA in LD3 to wild-type levels (23). We now asked whether the MP2 and MNC point mutations might act in cis to enable
the LD3-MP2-MNC RNA to be more efficiently incorporated by wild-type Gag proteins than LD3 viral RNA. To pursue this subject, Gag production was eliminated from LD3 and from LD3-MP2-MNC, such that the potential cis effects of MP2 and MNC on viral RNA packaging could be
assessed. For this purpose, two stop codons were inserted at the sixth
and eighth amino acid positions in the MA protein to yield construct BH-
MA (Fig. 1A). Surprisingly, substantial levels of the Gag-derived proteins, p40 and p24, but not Pr55Gag, were detected in
transfected COS-7 cells by Western blots (Fig. 1B, lane 1). It was
later realized that the continuous presence of p40 and p24 was due to
reinitiation of translation from an "AUG" codon at the tenth amino
acid position in the CA coding region, an event that results in the
appearance of a p40 Gag product (6). To entirely terminate
Gag production, two stop codons were inserted at the 82nd and 85th
amino acid positions in the CA protein. As expected, no Gag expression
was now detected with BH-
CA in the transfected COS-7 cells (Fig. 1B,
lane 2). However, normal production of Env protein was seen (lane 2),
indicating efficient transfection and normal viral gene transcription.
The aforementioned four stop codons were then inserted into each of the
BH10, LD3, and LD3-MP2-MNC constructs in order to engineer clones
BH-DG, LD3-DG and LD3-MP2-MNC-DG, which were all defective in Gag
production and yet active in the generation of Env proteins, as seen on
Western blots (Fig. 1B, lanes 3, 4, and 5).
To further assess production of Gag protein from these recombinant
constructs, Western blots were conducted with monoclonal
antibodies
(MAbs) against HIV-1 matrix (MA) antigen. We found
that stop codons
inserted at the sixth and eighth positions in
MA completely arrested MA
expression (Fig.
1B, lane 1). In contrast,
stop codons inserted at the
82nd and 85th positions in CA still
allowed efficient synthesis of a MA
protein that was fused with
the first 81 amino acids of CA (lane 2).
When the two groups of
stop codons were recombined in the same
construct, no MA expression
was detected (lanes 3, 4, and 5).
Therefore, the inserted stop
codons in MA and CA are both necessary to
effectively eliminate
Gag production. It should be pointed out that a
truncated version
of CA protein (i.e., 81 amino acids) should still be
produced
at low levels by each of the BH-DG, LD3-DG, and LD3-MP2-MNC-DG
constructs because of weak translation initiation associated with
CA.
Since this low abundance peptide does not include the p2 and
NC
portions, wherein the compensatory mutations reside, they should
not
have significantly affected our cotransfection
assays.
Next, we cotransfected the above DNA clones with

DIS, a construct
that lacks the entire DIS sequence from nt +243 to +277
(Fig.
2A).
Since BH-DG, LD3-DG, and LD3-MP2-MNC-DG did not produce
Gag proteins,
they only transcribed viral RNA available for packaging
by the
wild-type Gag proteins from

DIS. Primer pair pD
(5'-CCAGAGGAGCTCTCTCGACGC-3'
[positions 672 to 692])-pA
(5'-CCATCGATCTAATTCTCCC-3' [positions
837 to 819]) was
designed in such a way that RT-PCR yielded different
lengths of DNA
products from BH-DG, LD3-DG, and

DIS (Fig.
2A).
To assess the possible preferential
synthesis of the shorter

DIS
fragment over either LD3 or BH10 in
competitive PCR using the
above-mentioned primer pair, similar amounts
of three types of
plasmid DNA were mixed as templates. Relative amounts
of BH10,
LD3, and

DIS plasmid DNA before mixing were first examined
using
primer pair pGAG1-pST that directs the amplification of a 119-bp
fragment from each of the three constructs (
23). We found
that
equivalent amounts of each plasmid DNA were synthesized (Fig.
2B,
lanes 1 to 9). When the mixed plasmid DNA samples were examined
in PCR
using primer pair pD-pA (lanes 10 to 12), the relative
amounts of
different plasmid DNA samples observed in a single
reaction were
similar to those detected individually with primer
pair pGAG1-pST.
Therefore, no preferential amplification of

DIS
product was seen in
our competitive PCR system, possibly due to
the limited difference in
length between the PCR products.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Schematic illustration of the LD3 and DIS
deletions. The DIS sequences are underlined. Deleted nucleotides are
indicated by dashed lines. RT-PCR using primer pair pD-pA yields DNA
products of 166 bp from wild-type BH10 RNA, 150 bp from LD3 RNA, and
131 bp from DIS RNA. (B) PCR using the BH10, LD3, and DIS plasmid
DNA. Each of the three types of plasmid DNA was first quantified
individually in separate reactions using primer pair pGAG1-pST (lanes 1 to 9) (23). The same plasmid samples were then mixed and
subjected to reactions using primer pair pD-pA (lanes 10 to 12). Three
dilutions were included to ensure the linear range of reactions. Lanes
13 and 14 represent negative controls with primer pairs pGAG1-pST and
pD-pA, respectively. (C) RT-PCR analysis of viral RNA in transfected
COS-7 cells. Total cellular RNA that was extracted from cell lysates
equivalent to 100 pg of HIV-1 p24 was subjected to RT-PCR. Three
dilutions, i.e., 1:1 (lane 1), 1:3 (lane 2), and 1:9 (lane 3), of each
RNA sample were measured. RNase A digestion was also performed as a
negative control to rule out any possible plasmid DNA contamination
(lane 4). Wild-type viral DNA standards of 101,
102, 103, and 104 copies were used
in RT-PCR to determine the linear range of the reactions. Combinations
of constructs in each transfection experiment are shown at the top of
the gels. (D) RT-PCR analysis of RNA that was extracted from virus
particles. Labeling of the lanes refers to that in panel C.
|
|
To minimally interfere with

DIS gene expression, 2 µg of

DIS
DNA was used, compared with 0.5 µg each of BH-DG, LD3-DG, and
LD3-MP2-MNC-DG, in cotransfection experiments involving two constructs,
and 0.25 µg of each was used in cotransfection experiments involving
three constructs. Cellular RNA from transfected COS-7 cells was
first
analyzed by RT-PCR. The results of Fig.
2C show that viral
RNA levels
from each of the constructs in cotransfection experiments
reflect the
relative amount of plasmid DNA used. For instance,
in cotransfection
experiment e, similar levels of viral RNA were
detected from BH-DG and
LD3-DG, both of which were much lower
than that from

DIS, since 0.25 µg of BH-DG or LD3-DG, in comparison
to 2 µg of

DIS, was used in
transfection. When the RNA content
in virus particles were examined,

DIS packaged moderately lower
levels of viral RNA than BH10 (Fig.
2Da). When LD3-DG was cotransfected
with

DIS, LD3-DG RNA was
detected in virus particles, but at
a level similar to that in cells
(Fig. 2Db). Similar observations
were made in cotransfection with

DIS and LD3-MP2-MNC-DG (Fig.
2Dc). However, when BH-DG was
cotransfected with

DIS, similar
levels of both viral RNAs were
detected in virus particles despite
the lower levels of BH-DG RNA in
cells (Fig. 2Dd). Therefore,
the BH-DG RNA was more efficiently
packaged into virus particles
than

DIS RNA; in contrast, the MP2 and
MNC point mutations did
not help LD3 RNA to be more efficiently
incorporated into virus
particles. To further test the above results,
cotransfection experiments
were performed with the three constructs.
When both LD3-DG and
BH-DG RNA were present in cells, BH-DG was much
more efficiently
packaged into virus particles than LD3-DG (Fig. 2De).
Although
the total levels of viral RNA in cotransfection f were
slightly
lower than those in cotransfection e, the BH-DG signal was
significantly
stronger than that of LD3-MP2-MNC-DG. Thus,
LD3-MP2-MNC-DG was
not able to successfully compete with BH-DG for
packaging (Fig.
2Df). Therefore, the nucleotide substitutions in MP2
and MNC cannot
help LD3 RNA to be more efficiently packaged via
cis-acting
mechanisms.
Substitutions of the T amino acid at position 12 in p2 with V, L,
I, C, or M can dramatically increase the infectiousness of BH-D1 mutant
viruses.
We have previously shown that the BH-D1 deletion
mutation, eliminating HIV sequences at nt +200 to +226, attenuated
viral replication. Long-term culture of the mutated virus in MT-2 cells led to a revertant containing a mutation at position 12 in p2, i.e.,
T12I (MP2), that helped to restore viral infectiousness to near
wild-type levels (25). We now sought to answer whether other amino acids at position 12 in p2 were also able to rescue the
BH-D1 deletion. Toward this end, the T12 in p2 in BH-D1 was substituted
by each of 19 other amino acids (Fig. 3)
(Table 1). Relevant recombinant DNA constructs were transfected into
COS-7 cells, and the progeny viruses thus generated were quantified on
the basis of CA Ag levels. Equivalent amounts of virus were used to
infect MT-2 cells and the infectiousness of each preparation was
determined by the formation of syncytia and RT activity in culture
fluids. The results of Table 1 show that
four amino acids, including V, L, C, and M, in addition to the
previously detected I, can help to correct the adverse effects of BH-D1
on virus replication. This subject was further evaluated by replication
kinetic studies (Fig. 4A). Viruses
containing either a G, K, D, or E at position 12 in p2 were barely
infectious. In contrast, when T12 was replaced with either V, L, I, C,
or M, the recombinant viruses thus generated were able to generate high
levels of RT activity (Fig. 4A). Among the five amino acids that could
play this role, C was the least efficient.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Schematic illustration of mutations in the U5 region,
CA, p2, and NC. The amino acid sequence of p2, as well as parts of the
CA and NC proteins, is shown. The arrows indicate viral protease
cleavage sites that result in formation of p2. The substituted
nucleotide in U5 or amino residues in CA, p2, and NC are underlined.
Nucleotides in U5 are numbered from the beginning of the U3 region. The
numbering of the amino acid positions starts from the first residue of
each protein. Secondary structural domains in the amino terminus of CA
protein (amino acids 1 to 151) are illustrated that include a
-hairpin ( ), seven -helixes (H1 to H7), and a cyclophilin A
(Cyp A) binding site located between H4 and H5 (14). The
V27I substitution in CA exists in H1. A sketch of the first Zn finger
motif, in which some of the second-site mutations are located, is shown
at the top of the figure. Interactions between the C, C, H, and C amino
residues and the Zn ion are indicated; moreover, the underlined V13,
F16, T24, and A25 amino acid residues are close in tertiary structure
and form a hydrophobic cleft that can interact with the loop
nucleotides of the region of viral genomic RNA SL3 (12).
|
|

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Replication kinetics of wild-type BH10 and mutated
viruses containing the BH-D1 deletion and substitutions of T12 in p2.
(B) Infectiousness of mutated viruses containing the BH-D2 deletion,
substitutions of T12 in p2, and a T24I point mutation in NC. (C) Growth
curves of mutated viruses possessing the BH-LD3 deletion, substitutions
of T12 in p2 and a T24I point mutation in NC. In these studies, 5 × 105 MT-2 cells were infected by viruses equivalent to 3 ng of p24 Ag. RT activity in culture fluids was determined at various
times. The D2-MP2-MNC and LD3-MP2-MNC constructs, both containing a
T12I substitution in p2 and a T24I mutation in NC, were generated
previously (24, 25) and served as positive controls. Mock
infections represent negative controls performed with heat-inactivated
BH10 virus.
|
|
The T12I substitution in p2 was also identified in revertants of the
BH-D2 and BH-LD3 mutated viruses (
23,
25). We therefore
wished to determine whether the amino acids shown to compensate
for
BH-D1 (see above), i.e., V, L, C, and M, were also able to
rescue the
BH-D2 and BH-LD3 defective viruses. Toward this end,
the T12 in the p2
of BH-D2 or BH-LD3 was changed to either V,
L, C, or M. In addition, a
mutation at position 24 in the NC protein,
termed MNC, was also
included in these constructs, since it has
been previously shown that
this mutation works synergistically
with the T12I mutation in p2 to
rescue both BH-D2 or BH-LD3 (
23,
25). The various
constructs, i.e., D2-V-MNC, D2-L-MNC, D2-C-MNC,
D2-M-MNC, LD3-V-MNC,
LD3-L-MNC, LD3-C-MNC, and LD3-M-MNC, were
transfected into COS-7 cells
and the progeny viruses thus generated
were used to infect MT-2 cells.
The results of Fig.
4B and C show
that all of the above-described
constructs produced viable viruses
in contrast to the noninfectiousness
of BH-D2 and BH-LD3. Therefore,
each of V, L, C, and M can help to
rescue the BH-D2 and BH-LD3
deletions. The C and L substitutions were
less efficient in this
regard than either V, I, or
M.
The W, D, and E amino acids at position 12 in p2 dramatically
decreased infectiousness of wild-type virus.
We next studied the
effects of other substitutions at position 12 in p2 on the replication
potential of wild-type BH10 virus. Accordingly, T12 in BH10 was changed
to each of 19 other amino acids. These various constructs were
transfected into COS-7 cells, and the progeny viruses thus generated
were quantified according to the levels of CA Ag. The infectiousness of
the viruses produced by these constructs was examined by infection of
MT-2 cells. The data showed that the T12W substitution in p2 abolished
viral replication and that T12D and T12E dramatically decreased viral
infectiousness (Fig. 5). Substitutions to
either L or F markedly diminished viral replication and yet were
permissive for production of high levels of RT activity after 10 days,
while I, P, and Y each only slightly delayed viral replication (Fig.
5). Therefore, in terms of impact on viral replication, the various
substitutions can be ranked as follows: W>D, E>L, F>I, P, Y>G, A,
V, S, C, M, H, K, R, N, Q.

View larger version (35K):
[in this window]
[in a new window]
|
FIG. 5.
Replication capacities of wild-type BH10 and mutated
viruses containing substitutions of T12 in p2. Mutations are
represented by single-letter abbreviations of amino acids. UAG is a
stop codon that was inserted at position 12 in p2. (A) Growth curves of
wild-type and mutated viruses after infection of MT-2 cells. (B) RT
activity in culture supernatants at day 7 after infection. Mock
represents a negative control performed with heat-inactivated wild-type
virus.
|
|
T12 is one of eight amino acids in the HIV-1 p2 and NC proteins that
are recognized and cleaved by the viral protease. Hence,
mutations of
T12 may affect the efficiency of cleavage at this
site and decrease
viral replication. To test this hypothesis,
the processing of Gag in
our various mutated viruses was examined
through short-term
radiolabeling and immunoprecipitation of viral
proteins. For this
purpose, we employed anti-CA MAb to detect
each of Pr55
Gag,
intermediate cleavage products, including p41/p39 and p25, as
well as
mature p24 in cell lysates (Fig.
6A). The
intensities
of the protein bands were quantified, and
the percentage of each
viral protein was plotted to assess the
efficiency of Gag processing
(Fig.
6B).

View larger version (46K):
[in this window]
[in a new window]
|
FIG. 6.
Processing of Gag precursor protein
Pr55Gag in wild-type BH10 and mutated viruses containing
substitutions of the T12 amino acid in p2. Mutations are represented by
single-letter abbreviations of substituted amino acids. (A) Transfected
COS-7 cells were labeled with L-[35S]Met and
L-[35S]Cys for 30 min and cultured for 1 h. Cells were then lysed, and the lysates were subjected to
immunoprecipitation through the use of MAb against CA (p24) Ag. The
observed viral proteins, including Pr55Gag, p41, p39, p25,
and p24, are labeled on the right of the gels. To clearly visualize the
p25 and p24 proteins in certain mutants, enlarged portions of the gels
are shown. Mock-transfected COS-7 cells were also labeled with
L-[35S]Met and
L-[35S]Cys and serve as a negative control.
(B) The intensities of the viral protein bands were quantified through
the use of the NIH Image Program, and the percentages of each viral
protein in mutant or wild-type virus were plotted. (C) After 1 h
in culture, labeled virus particles were pelleted from the supernatants
and analyzed on SDS-12% polyacrylamide gels. A portion of the gel was
enlarged to clearly show accumulation of p25 protein in the W mutant.
|
|
In the case of the BH-p2-12UAG construct, that produced a truncated Gag
protein (i.e., MA-CA-p2 but missing three amino acids
at the C terminus
of p2 because of the UAG stop codon), a protein
band of 39 kDa was
observed. When a number of aliphatic amino
acids, i.e., G, A, V, L, and
I, were substituted for T at position
12 in p2, we found that the
levels of Pr55
Gag diminished as the length of the side
chain of the amino acid
increased (Fig.
6A and B). Yet, this did not
directly correlate
to viral infectiousness, since the G, A, V, and I
mutants had
similar replication capacity (Fig.
5). Of these, the L
substitution
resulted in a modest accumulation of p25 (CA-p2) fusion
product
in comparison with wild type (T) (Fig.
6A and B); this result
correlates with the decreased infectiousness of the L mutant (Fig.
5).
Substitution of T12 in p2 by S, C, or M, the side chains of
which
contain hydroxyl or sulfur groups, did not affect the processing
of Gag
proteins (Fig.
6A and B). Mutation of T to the cyclic amino
acid P
resulted in significant accumulation of Pr55
Gag, diminished
levels of the intermediate p39 and p25 products,
as well as enhanced
cleavage of p24 from p25 (Fig.
6A and B).
Among the substitutions
involving the aromatic amino acids F,
Y, and W, W led to both enhanced
accumulation of p25 and slightly
different migration patterns for both
the p25 and p24 proteins
(Fig.
6A and B), deficits that may account for
the noninfectiousness
of the T12W mutant. In contrast, mutations to the
basic amino
acids H, K, or R yielded differential results, with both H
and
K causing an accumulation of Pr55
Gag, while R
facilitated cleavage between p2 and NC and led to the
rapid appearance
of the p25 and p24 products (Fig.
6A and B).
The acidic amino acids D
and E resulted in enhanced accumulation
of Pr55
Gag, the
appearance of the p41 intermediate protein, and a slightly
slower
migration rate of p25. Both N and Q mutants showed moderate
accumulation of Pr55
Gag.
After the radiolabeling, COS-7 cells were cultured for 1 h in
complete DMEM, after which culture supernatants were pelleted
by
ultracentrifugation and virus particles were lysed and analyzed
on
SDS-12% polyacrylamide gels. No viral protein signal was detected
in
the case of the BH-p2-12UAG construct; this confirms that this
construct was unable to produce virus particles (Fig.
6C). Among
all
amino acids, W resulted in a great accumulation of p25 (Fig.
6C) and
thus had the highest impact on processing of Pr55
Gag, a
result consistent with elimination of viral infectivity. The
levels of
pr55
Gag in some viruses appear to be low (lanes 1, 14, 16, 17, and 19);
yet, considering the low levels of p24/25, these viruses
still
exhibit similar ratios between Pr55
Gag and p24/p25 as
the wild-type BH10. We further examined levels
of full-length viral RNA
packaged by various recombinant virus
particles. The majority of the 19 amino acids used to substitute
for T at position 12 in p2 did not
markedly affect RNA encapsidation
(Fig.
7). However, W resulted in substantially
decreased levels
of viral RNA in virus particles (Fig.
7).

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 7.
Levels of viral RNA in wild-type virus and in mutated
viruses harboring substitutions at position 12 in p2. Levels of
full-length viral RNA were assessed by RT-PCR through the use of primer
pair pGAG1-pST (23). RNA samples were treated with DNase
to remove any contaminating DNA. RNA samples were also digested with
RNase A and then subjected to RT-PCR as a negative control to exclude
the possibility of DNA contamination. A negative control of wild-type
BH10 is shown in lane 1. RNA obtained from wild-type virus was diluted
1:2 and 1:4 before RT-PCR to ensure a linear range of these reactions
(lanes 23 and 24). Additional controls were performed with wild-type
DNA of 101, 102, 103, and
104 copies to determine the linear range of the reaction
(lanes 25 to 28). The results represent three independent experiments.
Band intensities were quantified with the NIH Image Program and
plotted. The amount of BH10 RNA was arbitrarily set at 1.0.
|
|
A V27I mutation in CA, together with a G575A substitution in the U5
region, can partially correct the attenuated infectiousness caused by
the T12D substitution in p2.
The T12W, T12D, and T12E mutations
severely impaired infectiousness of wild-type virus. To further study
these mutations, relevant viruses were cultured in MT-2 cells over
prolonged periods to generate revertant viruses with increased growth
potential. In the case of the construct containing the T12W
substitution, no formation of syncytia was observed after 8 weeks in
culture. In contrast, the T12D and T12E mutants showed rapid syncytium formation and high levels of RT activity after 6 weeks in culture. Conceivably, these latter substitutions may have served to stimulate the occurrence of other compensatory mutations that, in turn, enhanced
viral replication.
Therefore, a fragment of viral DNA (nt 1 to 2430) was amplified from
the genomes of the T12D and T12E revertant viruses. The
results of
cloning and sequencing of the T12E revertant virus
revealed that a
G-to-A nucleotide substitution had occurred, resulting
in a change of
codon GAG to AAG, i.e., amino acid E to K, at position
12 in p2. Thus,
the mutated T12E virus was rescued by a further
substitution of E to K. This finding is consistent with the result
that a substitution of T by
K at position 12 in p2 did not affect
viral replication (Fig.
5).
In the case of viruses that reverted from constructs containing the
T12D mutation, the results of cloning and sequencing revealed
that this
mutation was retained in the viral genome. Interestingly,
however, two
additional mutations were discovered through this
work, one in the U5
region (i.e., G575A) and the other in the
CA protein (i.e., V27I) (Fig.
3). We next performed site-directed
mutagenesis to generate constructs
to directly examine the roles
of these mutations in viral replication.
The results of Fig.
8 show that the G575A
substitution did not substantially improve
the infectiousness of
BH-p2-12D mutated virus, while V27I had
a significant effect in this
regard. Combining both G575A and
V27I within BH-p2-12D had a further
positive impact on infectivity
(Fig.
8). Therefore, the V27I mutation
in CA, together with the
G575A substitution in the U5 region, appeared
to be able to correct
the defective infectiousness of the T12D mutant.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 8.
The V27I mutation in CA, together with the G575A
substitution in the U5 region, stimulates growth of the BH-p2-12D
mutant. For details, see Fig. 4.
|
|
The V, L, M, F, and Y amino acid residues can play the same role as
I at position 24 in NC to rescue the BH-D2 mutated virus.
MNC was
frequently identified together with MP2 in tissue culture able to
rescue the BH-D2 and BH-LD3 deletion (25). It is
intriguing to know whether similar findings to those obtained with MP2
would be observed in the case of MNC. Toward this end, T24 was changed
to each of 19 other amino acids to generate constructs D2-MP2-NC24X
(Fig. 3). The infectiousness of the viruses from these constructs was
examined by infecting MT-2 cells. The results of Fig.
9 show that V, L, and M at position 24 in
NC were able to rescue the BH-D2 mutated virus as well as did an I
substitution. F and Y were less efficient in this regard. Therefore,
amino residues with long hydrophobic side chains are favored at
position 24 in NC to compensate for the BH-D2 deletion.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 9.
(A) Effects of various substitutions of the T24 residue
in NC on the infectiousness of the BH-D2 mutated viruses. Each
substitution is represented by the single-letter abbreviation of amino
acids. (B) The RT activity of each virus at day 7 after infection is
plotted to clearly show the difference of infectiousness between
viruses. For details, refer to Fig. 4.
|
|
The S, D, and N amino residues at position 24 in NC dramatically
decreased the infectiousness of wild-type virus.
Next, we inserted
the above substitutions of T24 into the wild-type virus to examine
their effects on viral replication. The results of Fig.
10 show that most of the substitutions
did not affect or only moderately affected viral infectivity. The S and N mutations substantially decreased viral replication, and D eliminated viral infectiousness. Therefore, the wild-type virus can use most of
the 20 amino acids at position 24 in NC without affecting viral replication. Of note, the presence of either C or H at position 24 in
NC did not affect viral growth. This result implies that the presence
of C or H at position 24 in NC does not interfere with the binding of
Zn2+ ion by the CCHC motif in the first zinc finger.

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 10.
(A) Growth curves of the BH10 viruses containing
substitutions of T24 in NC in MT-2 cells. (B) RT activity of each virus
at day 6 after infection is plotted as a bar graph to demonstrate the
difference of infectivity between viruses. For details, refer to Fig.
4.
|
|
Since NC is the major viral structural protein that determines viral
RNA packagin efficiency, the effects of the above NC
substitutions on
packaging was analyzed by RT-PCR. The results
of Fig.
11 show that the acidic amino acid
residue D displayed
the most adverse impact in this regard, while G, A,
S, H, R, E,
and N moderately diminished viral RNA packaging.

View larger version (74K):
[in this window]
[in a new window]
|
FIG. 11.
Viral genomic RNA levels in the BH10 viruses containing
various substitutions of the T24 residue in NC. Substitutions are
represented by the single letters of amino acids. Viral RNA from
viruses equivalent to 200 pg of CA antigen was subjected to RT-PCR
using primer pair pGAG1-pST (23). The intensity of each
band was quantified by the NIH Image program and plotted.
|
|
To gain further insight into the mechanisms whereby S, D, and N at
position 24 in NC could affect HIV-1 replication, these
mutant viruses
were cultured in MT-2 cells for a prolonged period.
Wild-type
replication kinetics were observed for S and N, while
neither
cytopathology nor RT activity were detected in cultures
in the case of
the D mutant, even after 3 months. The results
of cloning and
sequencing of the S revertant virus revealed that
the S amino acid had
been changed to an L, which was shown to
confer wild-type infectivity
to the virus (Fig.
10). In the case
of the N revertant, N was retained
at position 24 in NC, while
the V13 amino acid in NC was changed to a G
(Fig.
3). When T24N
and V13G were recombined through site-directed
mutagenesis, the
virus thus generated, i.e., BH-V13G-T24N, showed
wild-type replication
capacity in MT-2 cells (Fig.
12A). The results of RT-PCR indicated
that this BH-V13G-T24N recombinant virus packaged wild-type levels
of
viral RNA (Fig.
12B).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 12.
(A) Infectiousness of the BH10 wild-type virus and the
BH-T24N, as well as BH-V13G-T24N mutated viruses in MT-2 cells. (B)
Viral genomic RNA levels in the wild-type and mutated viruses
determined by RT-PCR using primer pair pGAG1-pST. RNA samples of each
virus were diluted 1:2 and 1:4 to ensure the linear range of the
reactions. Wild-type viral DNA standards of 101,
102, 103, and 104 copies were used
to determine the linear range of reactions. Lane 1, viral RNA from
viruses equivalent to 200 pg of CA Ag; lane 2, 100 pg of CA Ag; lane 3, 50 pg of CA Ag. Intensity of RNA signals was quantified using the NIH
Image program with the levels of wild-type BH10 arbitrarily set at
1.0.
|
|
 |
DISCUSSION |
We have previously deleted various sequences between the
primer-binding site and the 5' SD site that impact on viral RNA
packaging and dimerization. Interestingly, long-term culture of all the mutated viruses gave rise to the MP2 and MNC compensatory mutations in
the Gag protein (23, 25). In this study, we further showed that, in addition to the MP2 (T12I in p2) substitution that was identified in culture, amino acids V, L, M, and C at position 12 in p2
can also rescue the aforementioned deletions. Among them, V, L, I, and
M rescued the impaired infectivity of the mutated viruses to similar
levels, while C acted in this regard to a lower extent. Similar
findings were made with the MNC mutation (T24I in NC). Screening
studies identified six amino acids, including V, L, I, M, F, and Y, at
position 24 in NC that can help to rescue the deletions; among these, F
and Y are the least efficient.
Our data argue that a nucleotide change from C to T in the MP2 and MNC
mutations did not exert compensatory effects in a cis manner. The results of cotransfection experiments demonstrated that the
nucleotide change from C to T in MP2 and MNC did not overcome the
crippled packaging efficiency of the LD3 viral RNA (Fig. 2).
Furthermore, the V, L, I, and M amino acids are coded for by different
nucleotides, yet they all can rescue the LD3 deletions when present at
position 12 in p2 and at position 24 in NC. Therefore, it is the
hydrophobic nature of the substituted amino residues at position 12 in
p2 and at position 24 in NC, rather than the altered nucleotides
themselves, that rescued the deletion mutations.
One question concerning these findings is why only the I residue was
identified in culture if the V, L, and M amino acids can also replace
the T12 in p2 or T24 in NC to rescue the mutated viruses. This may
simply be because only a single nucleotide change, i.e., ACC
AUC, is
required to achieve a T-to-I substitution; however, each of the other
amino acid changes require mutations at two or three base positions. It
is also noted from the above results that the V, L, I, and M residues
are identified both in p2 and in NC as the most efficient ones in the
rescue process. Since V, L, I, and M are selected from 20 amino acids
and all contain long hydrophobic side chains, we hypothize that
specific interactions of a hydrophobic nature involving these residues
in p2 and NC with other sequence of Gag or with viral RNA are essential
to the rescue of the BH-D1, BH-D2, and BH-LD3 mutated viruses.
In addition to SL1, several other RNA elements are also involved in
HIV-1 RNA packaging. Based on their affinity to the Gag protein, as
assessed by in vitro binding experiments, the involved RNA elements can
be divided into two groups. The TAR and poly(A) hairpin show low
affinity for Gag, while SL1 and SL3 exhibit high affinity (5,
8). It is understood that SL1 and SL3 contribute to the
packaging process through their tight binding to Gag, yet the mechanism
remains elusive by which TAR and the poly(A) hairpin affect RNA
packaging. Because of the multipartite nature of packaging signals,
mutation of either one of these signals cannot totally exclude viral
RNA from virus particles. Moreover, the mutated viruses may revert by
modifying the Gag protein to increase its binding affinity to the
unchanged packaging signals, so that the RNA packaging in the mutated
viruses can be restored to wild-type levels. Our compensation analysis
of the SL1 sequence may be an example of this kind.
The nuclear magnetic resonance (NMR) structure of the NL4-3 NC and the
SL3 RNA complex indicated a direct contact between the I24 residue of
NC and SL3 RNA, which implies that I24 participates in packaging
(12). However, the 24th position of NC in BH10 is occupied
by a T residue. Since multiple RNA elements are involved in the
packaging process, although the NC of BH10 contains a T24 residue and
may show a low affinity to SL3, interactions of NC with SL1 or other
viral RNA elements may still allow the virus to recruit wild-type
levels of viral RNA. However, when the SL1 RNA sequence is deleted, a
T24I change is necessary to strengthen the interactions between NC and
SL3 RNA, such that the mutant virus can package wild-type levels of
viral RNA. Since V, L, and M contain similar hydrophobic side chains to
I, they may establish similar interactions with SL3 RNA when present at
position 24 in NC and correct the defective viral RNA packaging in the
mutated viruses.
Another interesting finding is that a substitution of T24N in the first
zinc finger motif of NC in BH10 can be compensated for by another point
mutation, i.e., V13A in the same zinc finger. According to the NMR
structure of NC and the SL3 RNA complex, the V13 and I24 amino acid
residues, together with F16 and A25, form a hydrophobic cleft to which
the G9 of SL3 can bind. Moreover, V13 and I24 contribute to
the formation of a compact structure of NC by hydrophobic interactions
with F6 (12). Therefore, V13 and I24 are important
residues in NC. It is possible that substitution of T24 in BH10 with N
may introduce steric interference with the V13 residue and further lead
to distortion of NC conformation. The G amino acid contains an -H as
its side chain and therefore can release the possible steric hindrance when substituted for V13. This issue needs to be tested by NMR analysis
of the mutated NC protein binding to the SL3 RNA.
It is also interesting that the V27I substitution in CA can stimulate
growth of the BH-p2-12D mutant. V27 is located in a region that forms
"helix 1" in the CA protein (14, 15) (Fig. 3). Both
crystallographic and mutagenesis studies suggest that proteolysis
between MA and CA is followed by refolding and that the helices of two
distinct CA molecules, including "helix 1," then create a new CA-CA
interface essential for the formation of a condensed conical core
(36). The V27I mutation may adjust this process to correct
deficits caused by the T12D mutation in p2. On the other hand,
identification of the V27I mutation in CA also suggests possible
interactions of p2 with certain regions of CA.
Proteolytic cleavage of Gag gives rise to four distinct proteins, i.e.,
MA, CA, NC, and p6. Although the structure of each of these proteins
has been determined, their conformation within the context of the Gag
protein is not fully resolved. The fact that wild-type virus can
successfully accommodate 15 of 20 amino acids at position 12 in p2
suggests that this residue is not normally involved in crucial
interactions with other regions of Gag. However, the presence of some
amino acids at this position, e.g., W, D, or E, may conceivably exert
negative effects on Gag conformation and may, therefore, result in
abnormal Gag processing, RNA packaging, and viral replication. The V,
L, I, and M substitutions may have established novel interactions that
are crucial for the viability of the deleted virus but insignificant in
regard to wild-type virus.
 |
ACKNOWLEDGMENTS |
This research was supported by grants from the Canadian
Institutes of Health Research (CIHR).
We thank Mervi Detorio and Maureen Oliveira for technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: McGill AIDS
Centre, Lady Davis Institute-Jewish General Hospital, 3755 Cote
Ste-Catherine Rd., Montreal, Quebec, Canada H3T 1E2. Phone: (514)
340-8260. Fax: (514) 340-7537. E-mail for Mark A. Wainberg:
mdwa{at}musica.mcgill.ca. E-mail for Chen Liang:
cliang{at}po-box.mcgill.ca.
 |
REFERENCES |
| 1.
|
Awang, G., and D. Sen.
1993.
Mode of dimerization of HIV-1 genomic RNA.
Biochemistry
32:11453-11457[CrossRef][Medline].
|
| 2.
|
Baudin, G.,
R. Marquet,
C. Isel,
J. L. Darlix,
B. Ehresmann, and C. Ehresmann.
1993.
Functional sites in the 5' region of human immunodeficiency virus type 1 RNA form defined structural domains.
J. Mol. Biol.
229:382-397[CrossRef][Medline].
|
| 3.
|
Berkhout, B., and J. L. B. van Wamel.
1996.
Role of the DIS hairpin in replication of human immunodeficiency virus type 1.
J. Virol.
70:6723-6732[Abstract/Free Full Text].
|
| 4.
|
Berkowitz, R. D.,
J. Fisher, and S. P. Goff.
1996.
RNA packaging.
Curr. Top. Microbiol. Immunol.
214:177-218[Medline].
|
| 5.
|
Berkowitz, R. D., and S. P. Goff.
1994.
Analysis of binding elements in the human immunodeficiency virus type 1 genomic RNA and nucleocapsid protein.
Virology
202:233-246[CrossRef][Medline].
|
| 6.
|
Buck, C. B.,
X. Shen,
M. A. Egan,
T. C. Pierson,
C. M. Walker, and R. F. Siliciano.
2001.
The human immunodeficiency virus type 1 gag gene encodes an internal ribosome entry site.
J. Virol.
75:181-191[Abstract/Free Full Text].
|
| 7.
|
Clever, J. L., and T. G. Parslow.
1997.
Mutant human immunodeficiency virus type 1 genomes with defects in RNA dimerization or encapsidation.
J. Virol.
71:3407-3414[Abstract].
|
| 8.
|
Clever, J.,
C. Sassetti, and T. G. Parslow.
1995.
RNA secondary structure and binding sites for gag gene products in the 5' packaging signal of human immunodeficiency virus type 1.
J. Virol.
69:2101-2109[Abstract].
|
| 9.
|
Clever, J. L.,
M. L. Wong, and T. G. Parslow.
1996.
Requirement for kissing-loop-mediated dimerization of human immunodeficiency virus RNA.
J. Virol.
70:5902-5908[Abstract].
|
| 10.
|
Das, A. T.,
B. Klaver, and B. Berkhout.
1998.
The 5' and 3' TAT elements of human immunodeficiency virus exert effects at several points in the virus life cycle.
J. Virol.
72:9217-9223[Abstract/Free Full Text].
|
| 11.
|
Das, A. T.,
B. Klaver,
B. I. F. Klasens,
J. L. B. van Wamel, and B. Berkhout.
1997.
A conserved hairpin motif in the R-U5 region of the human immunodeficiency virus type 1 genome is essential for replication.
J. Virol.
71:2346-2356[Abstract].
|
| 12.
|
De Guzman, R. N.,
Z. R. Wu,
C. C. Stalling,
L. Pappalardo,
P. N. Borer, and M. F. Summers.
1998.
Structure of the HIV-1 nucleocapsid protein bound to the SL3 -RNA recognition element.
Science
279:384-388[Abstract/Free Full Text].
|
| 13.
|
Fu, W.,
R. J. Gorelick, and A. Rein.
1994.
Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.
J. Virol.
68:5013-5018[Abstract/Free Full Text].
|
| 14.
|
Gamble, T. R.,
F. F. Vajdos,
S. Yoo,
D. K. Worthylake,
M. Houseweart,
W. I. Sundquist, and C. P. Hill.
1996.
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.
Cell
87:1285-1294[CrossRef][Medline].
|
| 15.
|
Gitti, R. K.,
B. M. Lee,
J. Walker,
M. F. Summers,
S. Yoo, and W. I. Sundquist.
1996.
Structure of the amino-terminal core domain of the HIV-1 capsid protein.
Science
273:231-235[Abstract].
|
| 16.
|
Harrich, D.,
C. W. Hooker, and E. Parry.
2000.
The human immunodeficiency virus type 1 TAR RNA upper stem-loop plays distinct roles in reverse transcription and RNA packaging.
J. Virol.
74:5639-5646[Abstract/Free Full Text].
|
| 17.
|
Harrison, G. P., and A. M. L. Lever.
1992.
The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure.
J. Virol.
66:4144-4153[Abstract/Free Full Text].
|
| 18.
|
Helga-Maria, C.,
M. L. Hammarskjold, and D. Rekosh.
1999.
An intact TAR element and cytoplasmic localization are necessary for efficiency packaging of human immunodeficiency virus type 1 genomic RNA.
J. Virol.
73:4127-4135[Abstract/Free Full Text].
|
| 19.
|
Kaddrick, M.,
A. L. Lear,
A. J. Cann, and S. Heaphy.
1996.
Evidence that a kissing loop structure facilitates genomic RNA dimerization in HIV-1.
J. Mol. Biol.
259:58-68[CrossRef][Medline].
|
| 20.
|
Laughrea, M., and L. Jette.
1994.
A 19-nucleotide sequence upstream of the 5' major splice donor is part of the dimerization domain of human immunodeficiency virus 1 genomic RNA.
Biochemistry
33:13464-13474[CrossRef][Medline].
|
| 21.
|
Laughrea, M., and L. Jette.
1996.
Kissing-loop model of HIV-1 genome dimerization: HIV-1 RNAs can assume alternative dimeric forms, and all sequences upstream or downstream of hairpin 248-271 are dispensible for dimer formation.
Biochemistry
35:1589-1598[CrossRef][Medline].
|
| 22.
|
Laughrea, M., and L. Jette.
1996.
HIV-1 genomic dimerisation: formation kinetics and thermal stability of dimeric HIV-1 LAI RNAs are not improved by the 1-232 and 292-790 regions flanking the kissing loop domain.
Biochemistry
35:9366-9374[CrossRef][Medline].
|
| 23.
|
Liang, C.,
L. Rong,
M. Laughrea,
L. Kleiman, and M. A. Wainberg.
1998.
Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication.
J. Virol.
72:6629-6636[Abstract/Free Full Text].
|
| 24.
|
Liang, C.,
L. Rong,
Y. Quan,
M. Laughrea,
L. Kleiman, and M. A. Wainberg.
1999.
Mutations within four distinct Gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.
J. Virol.
73:7014-7020[Abstract/Free Full Text].
|
| 25.
|
Liang, C.,
L. Rong,
R. S. Russell, and M. A. Wainberg.
2000.
Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene.
J. Virol.
74:6251-6261[Abstract/Free Full Text].
|
| 26.
|
Marquet, R.,
J. C. Paillart,
E. Skripkin,
C. Ehresmann, and B. Ehresmann.
1994.
Dimerization of human immunodeficiency virus type 1 RNA involves sequences located upstream of the splice donor site.
Nucleic Acids Res.
22:145-151[Abstract/Free Full Text].
|
| 27.
|
McBride, M. S., and A. T. Panganiban.
1996.
The human immunodeficiency virus type 1 encapsidation site is a multipartite RNA element composed of functional hairpin structures.
J. Virol.
70:2963-2973[Abstract].
|
| 28.
|
McBride, M. S., and A. T. Panganiban.
1997.
Position dependence of functional hairpins important for human immunodeficiency virus type 1 RNA encapsidation in vivo.
J. Virol.
71:2050-2058[Abstract].
|
| 29.
|
McBride, M. S.,
M. D. Schwartz, and A. T. Panganiban.
1997.
Efficiency encapsidation of human immunodeficiency virus type 1 vectors and further characterization of cis elements required for encapsidation.
J. Virol.
71:4544-4554[Abstract].
|
| 30.
|
Muriaux, D.,
P. M. Girard,
B. Bonnet-Mathoniere, and J. Paoletti.
1995.
Dimerization of HIV-1 LAI at low ionic strength. An autocomplementary sequence in the 5' leader region is evidenced by an antisense oligonucleotide.
J. Biol. Chem.
270:8209-8216[Abstract/Free Full Text].
|
| 31.
|
Paillart, J. C.,
L. Berthoux,
M. Ottmann,
J. L. Darlix,
R. Marquet,
B. Ehresmann, and C. Ehresmann.
1996.
A dual role of the putative RNA dimerization initiation site of HIV-1 in genomic RNA packaging and proviral synthesis.
J. Virol.
70:8348-8354[Abstract].
|
| 32.
|
Paillart, J. C.,
R. Marquet,
E. Skripkin,
B. Ehresmann, and C. Ehresmann.
1994.
Mutational analysis of the bipartite dimer linkage structure of human immunodeficiency virus type 1 genomic RNA.
J. Biol. Chem.
269:27486-27493[Abstract/Free Full Text].
|
| 33.
|
Paillart, J. C.,
E. Skripkin,
B. Ehresmann,
C. Ehresmann, and R. Marquet.
1996.
A loop-loop "kissing" complex is the essential part of the dimer linkage of genomic HIV-1 RNA.
Proc. Natl. Acad. Sci. USA
93:5572-5577[Abstract/Free Full Text].
|
| 34.
|
Paillart, J. C.,
E. Westhof,
C. Ehresmann,
B. Ehresmann, and R. Marquet.
1997.
Noncanonical interactions in a kissing loop complex: the dimerisation initiation site of HIV-1 genomic RNA.
J. Mol. Biol.
270:36-49[CrossRef][Medline].
|
| 35.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 36.
|
Schwedler, U. K.,
T. L. Stemmler,
V. Y. Klishko,
S. Li,
K. H. Albertine,
D. R. Davis, and W. I. Sundquist.
1998.
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
EMBO J.
17:1555-1568[CrossRef][Medline].
|
| 37.
|
Skripkin, E.,
J. C. Paillart,
R. Marquet,
B. Ehresmann, and C. Ehresmann.
1994.
Identification of the primary site of human immunodeficiency virus type 1 RNA dimerization in vitro.
Proc. Natl. Acad. Sci. USA
91:4945-4949[Abstract/Free Full Text].
|
Journal of Virology, August 2001, p. 7230-7243, Vol. 75, No. 16
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7230-7243.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Didierlaurent, L., Houzet, L., Morichaud, Z., Darlix, J.-L., Mougel, M.
(2008). The conserved N-terminal basic residues and zinc-finger motifs of HIV-1 nucleocapsid restrict the viral cDNA synthesis during virus formation and maturation. Nucleic Acids Res
36: 4745-4753
[Abstract]
[Full Text]
-
Ooms, M., Huthoff, H., Russell, R., Liang, C., Berkhout, B.
(2004). A Riboswitch Regulates RNA Dimerization and Packaging in Human Immunodeficiency Virus Type 1 Virions. J. Virol.
78: 10814-10819
[Abstract]
[Full Text]
-
Russell, R. S., Roldan, A., Detorio, M., Hu, J., Wainberg, M. A., Liang, C.
(2003). Effects of a Single Amino Acid Substitution within the p2 Region of Human Immunodeficiency Virus Type 1 on Packaging of Spliced Viral RNA. J. Virol.
77: 12986-12995
[Abstract]
[Full Text]
-
Liang, C., Hu, J., Russell, R. S., Roldan, A., Kleiman, L., Wainberg, M. A.
(2002). Characterization of a Putative {alpha}-Helix across the Capsid-SP1 Boundary That Is Critical for the Multimerization of Human Immunodeficiency Virus Type 1 Gag. J. Virol.
76: 11729-11737
[Abstract]
[Full Text]